Safety and efficacy of elapegademase in patients with adenosine deaminase deficiency: A multicenter, open‐label, single‐arm, phase 3, and postmarketing clinical study
- DOI
- 10.1002/iid3.917
- Published
- 2023-07
- Container
- Immunity, Inflammation and Disease
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/iid3.917,
title = {Safety and efficacy of elapegademase in patients with adenosine deaminase deficiency: A multicenter, open‐label, single‐arm, phase 3, and postmarketing clinical study},
author = {Masafumi Onodera and Toru Uchiyama and Tadashi Ariga and Masafumi Yamada and Takako Miyamura and Hironori Arizono and Tomohiro Morio},
year = {2023},
journal = {Immunity, Inflammation and Disease},
doi = {10.1002/iid3.917},
url = {https://doi.org/10.1002/iid3.917}
}RIS
TY - JOUR TI - Safety and efficacy of elapegademase in patients with adenosine deaminase deficiency: A multicenter, open‐label, single‐arm, phase 3, and postmarketing clinical study AU - Masafumi Onodera AU - Toru Uchiyama AU - Tadashi Ariga AU - Masafumi Yamada AU - Takako Miyamura AU - Hironori Arizono AU - Tomohiro Morio PY - 2023 JO - Immunity, Inflammation and Disease DO - 10.1002/iid3.917 UR - https://doi.org/10.1002/iid3.917 ER -
APA
Onodera, M., Uchiyama, T., Ariga, T., Yamada, M., Miyamura, T., Arizono, H., & Morio, T. (2023). Safety and efficacy of elapegademase in patients with adenosine deaminase deficiency: A multicenter, open‐label, single‐arm, phase 3, and postmarketing clinical study. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.917
Source records
- crossref · retrieved 2026-09-26T23:15:11.200Z